Armonil en es it fr

Armonil Brand names, Armonil Analogs

Armonil Brand Names Mixture

  • No information avaliable

Armonil Chemical_Formula

C16H13ClN2O

Armonil RX_link

http://www.rxlist.com/cgi/generic/diazepam.htm

Armonil fda sheet

Armonil msds (material safety sheet)

Armonil MSDS

Armonil Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Armonil Molecular Weight

284.74 g/mol

Armonil Melting Point

125-126oC

Armonil H2O Solubility

Slightly soluble (50 mg/L)

Armonil State

solid

Armonil LogP

2.988

Armonil Dosage Forms

Tablets; Injectable solution

Armonil Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Armonil Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Armonil Absorption

Essentially complete, with a bioavailability of 93%.

Armonil side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Armonil Patient Information

Armonil Organisms Affected

Humans and other mammals